{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:38:08Z","timestamp":1794062288666,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17953"],"award-info":[{"award-number":["20K17953"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07810"],"award-info":[{"award-number":["20K07810"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K19810"],"award-info":[{"award-number":["17K19810"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K10117"],"award-info":[{"award-number":["15K10117"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K10520"],"award-info":[{"award-number":["16K10520"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K01842"],"award-info":[{"award-number":["15K01842"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09451"],"award-info":[{"award-number":["19K09451"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atherosclerosis has been considered as the main cause of morbidity, mortality, and disability worldwide. The first screening for antigen markers was conducted using the serological identification of antigens by recombinant cDNA expression cloning, which has identified adaptor-related protein complex 3 subunit delta 1 (AP3D1) as an antigen recognized by serum IgG antibodies of patients with atherosclerosis. Serum antibody levels were examined using the amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA) using a recombinant protein as an antigen. It was determined that the serum antibody levels against AP3D1 were higher in patients with acute ischemic stroke\u00a0(AIS), transient ischemic attack, diabetes mellitus (DM), cardiovascular disease, chronic kidney disease (CKD), esophageal squamous cell carcinoma (ESCC), and colorectal carcinoma than those in the healthy donors. The area under the curve values of DM, nephrosclerosis type of CKD, and ESCC calculated using receiver operating characteristic curve analysis were higher than those of other diseases. Correlation analysis showed that the anti-AP3D1 antibody levels were highly associated with maximum intima-media thickness, which indicates that this marker reflected the development of atherosclerosis. The results of the Japan Public Health Center-based Prospective Study indicated that this antibody marker is deemed useful as risk factors for AIS.<\/jats:p>","DOI":"10.1038\/s41598-021-92786-9","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T10:06:39Z","timestamp":1624961199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Shu-Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Matsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Iso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Tsugane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahiro","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sumazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuro","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Tomiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Shinmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Iwadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Hiwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"92786_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1189\/jlb.3MA0717-283","volume":"103","author":"CM Weyand","year":"2018","unstructured":"Weyand, C. M., Berry, G. J. & Goronzy, J. J. The immunoinhibitory PD-1\/PD-L1 pathway in inflammatory blood vessel disease. J. Leukoc. Biol. 103, 565\u2013575. https:\/\/doi.org\/10.1189\/jlb.3MA0717-283 (2018) (PMID: 28848042).","journal-title":"J. Leukoc. Biol."},{"key":"92786_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrcardio.2017.118","volume":"15","author":"E Bartoloni","year":"2018","unstructured":"Bartoloni, E., Alunno, A. & Gerli, R. Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat. Rev. Cardiol. 15, 33\u201344. https:\/\/doi.org\/10.1038\/nrcardio.2017.118 (2018) (PMID: 28836617).","journal-title":"Nat. Rev. Cardiol."},{"key":"92786_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5853\/jos.2017.01830","volume":"19","author":"JS Kim","year":"2017","unstructured":"Kim, J. S. & Bang, O. Y. Medical treatment of intracranial atherosclerosis: An update. J. Stroke 19, 261\u2013270. https:\/\/doi.org\/10.5853\/jos.2017.01830 (2017) (PMID: 29037012).","journal-title":"J. Stroke"},{"key":"92786_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5483\/bmbrep.2014.47.1.285","volume":"47","author":"S Lim","year":"2014","unstructured":"Lim, S. & Park, S. Role of vascular smooth muscle cell in the inflammation of atherosclerosis. BMB Rep. 47, 1\u20137. https:\/\/doi.org\/10.5483\/bmbrep.2014.47.1.285 (2014) (PMID: 24388105).","journal-title":"BMB Rep."},{"key":"92786_CR5","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.atv.20.5.1262","volume":"20","author":"R Virmani","year":"2000","unstructured":"Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A. & Schwartz, S. M. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262\u20131275. https:\/\/doi.org\/10.1161\/01.atv.20.5.1262 (2000) (PMID: 10807742).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"92786_CR6","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/ijms21051835","volume":"21","author":"A Poznyak","year":"2020","unstructured":"Poznyak, A. et al. The diabetes mellitus-atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation. Int. J. Mol. Sci. 21, 1835. https:\/\/doi.org\/10.3390\/ijms21051835 (2020) (PMID: 32155866).","journal-title":"Int. J. Mol. Sci."},{"key":"92786_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrneph.2010.143","volume":"6","author":"TB Dr\u00fceke","year":"2010","unstructured":"Dr\u00fceke, T. B. & Massy, Z. A. Atherosclerosis in CKD: Differences from the general population. Nat. Rev. Nephrol. 6, 723\u2013735. https:\/\/doi.org\/10.1038\/nrneph.2010.143 (2010) (PMID: 20978469).","journal-title":"Nat. Rev. Nephrol."},{"key":"92786_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.arcmed.2017.03.005","volume":"48","author":"JV Tapia-Vieyra","year":"2017","unstructured":"Tapia-Vieyra, J. V., Delgado-Coello, B. & Mas-Oliva, J. Atherosclerosis and cancer: A resemblance with far-reaching implications. Arch. Med. Res. 48, 12\u201326. https:\/\/doi.org\/10.1016\/j.arcmed.2017.03.005 (2017).","journal-title":"Arch. Med. Res."},{"key":"92786_CR9","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1001\/jama.296.24.2939","volume":"296","author":"R Carandang","year":"2006","unstructured":"Carandang, R. et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296, 2939\u20132946. https:\/\/doi.org\/10.1001\/jama.296.24.2939 (2006).","journal-title":"JAMA"},{"key":"92786_CR10","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.107.743211","volume":"118","author":"M Kubo","year":"2008","unstructured":"Kubo, M. et al. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation 118, 2672\u20132678. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.743211 (2008).","journal-title":"Circulation"},{"key":"92786_CR11","doi-asserted-by":"publisher","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","volume":"92","author":"U Sahin","year":"1995","unstructured":"Sahin, U. et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92, 11810\u201311813. https:\/\/doi.org\/10.1073\/pnas.92.25.11810 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"92786_CR12","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","volume":"94","author":"YT Chen","year":"1997","unstructured":"Chen, Y. T. et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94, 1914\u20131918. https:\/\/doi.org\/10.1073\/pnas.94.5.1914 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"92786_CR13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/ijc.20517","volume":"112","author":"K Nakashima","year":"2004","unstructured":"Nakashima, K. et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int. J. Cancer 112, 1029\u20131035. https:\/\/doi.org\/10.1002\/ijc.20517 (2004).","journal-title":"Int. J. Cancer"},{"key":"92786_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3892\/ijo.28.2.463","volume":"28","author":"M Kuboshima","year":"2006","unstructured":"Kuboshima, M. et al. Identification of a novel SEREX antigen, SLC2A1\/GLUT1, in esophageal squamous cell carcinoma. Int. J. Oncol. 28, 463\u2013468. https:\/\/doi.org\/10.3892\/ijo.28.2.463 (2006).","journal-title":"Int. J. Oncol."},{"key":"92786_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1349-7006.2006.00192.x","volume":"97","author":"M Kuboshima","year":"2006","unstructured":"Kuboshima, M. et al. Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Sci. 97, 380\u2013386 (2006).","journal-title":"Cancer Sci."},{"key":"92786_CR16","first-page":"97","volume":"30","author":"H Shimada","year":"2007","unstructured":"Shimada, H. et al. Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma. Int. J. Oncol. 30, 97\u2013103 (2007).","journal-title":"Int. J. Oncol."},{"key":"92786_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0393-4","volume":"13","author":"T Machida","year":"2015","unstructured":"Machida, T. et al. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX). J. Transl. Med. 13, 1\u201311 (2015).","journal-title":"J. Transl. Med."},{"key":"92786_CR18","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.18632\/oncotarget.23653","volume":"9","author":"Y Yoshida","year":"2018","unstructured":"Yoshida, Y. et al. Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack. Oncotarget 9, 8836\u20138848. https:\/\/doi.org\/10.18632\/oncotarget.23653 (2018).","journal-title":"Oncotarget"},{"key":"92786_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2176\/nmc.ra.2018-0022","volume":"58","author":"Y Yoshida","year":"2018","unstructured":"Yoshida, Y. et al. Elevation of autoantibody in patients with ischemic stroke. Neurol. Med. Chir. (Tokyo) 58, 303\u2013310. https:\/\/doi.org\/10.2176\/nmc.ra.2018-0022 (2018).","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"92786_CR20","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.18632\/oncotarget.23789","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. Oncotarget 9, 5600\u20135613. https:\/\/doi.org\/10.18632\/oncotarget.23789 (2018).","journal-title":"Oncotarget"},{"key":"92786_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04661","volume":"6","author":"Y Yoshida","year":"2020","unstructured":"Yoshida, Y. et al. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases. Heliyon 6, e04661. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04661 (2020).","journal-title":"Heliyon"},{"key":"92786_CR22","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3892\/ijmm.2020.4690","volume":"46","author":"SY Li","year":"2020","unstructured":"Li, S. Y. et al. Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension. Int. J. Mol. Med. 46, 1274\u20131288. https:\/\/doi.org\/10.3892\/ijmm.2020.4690 (2020).","journal-title":"Int. J. Mol. Med."},{"key":"92786_CR23","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1111\/cas.14652","volume":"111","author":"M Sumazaki","year":"2020","unstructured":"Sumazaki, M. et al. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases. Cancer Sci. 111, 4453\u20134464. https:\/\/doi.org\/10.1111\/cas.14652 (2020).","journal-title":"Cancer Sci."},{"key":"92786_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams, H. P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35\u201341. https:\/\/doi.org\/10.1161\/01.str.24.1.35 (1993).","journal-title":"Stroke"},{"key":"92786_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000157629","volume":"29","author":"R Nishiura","year":"2009","unstructured":"Nishiura, R. et al. Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. Am. J. Nephrol. 29, 257\u2013263 (2009).","journal-title":"Am. J. Nephrol."},{"key":"92786_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000197116","volume":"30","author":"H Komatsu","year":"2009","unstructured":"Komatsu, H. et al. Recent therapeutic strategies improve renal outcome in patients with IgA nephropathy. Am. J. Nephrol. 30, 19\u201325 (2009).","journal-title":"Am. J. Nephrol."},{"key":"92786_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1477-5956-9-31","volume":"9","author":"A Kagaya","year":"2011","unstructured":"Kagaya, A. et al. Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma. Proteome Sci. 9, 31. https:\/\/doi.org\/10.1186\/1477-5956-9-31 (2011).","journal-title":"Proteome Sci."},{"key":"92786_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4172\/1948-5956.1000326","volume":"07","author":"H Shimada","year":"2015","unstructured":"Shimada, H. et al. Elevated serum antibody levels against cyclin L2 in patients with esophageal squamous cell carcinomai. J. Cancer Sci. Ther. 07, 60\u201366. https:\/\/doi.org\/10.4172\/1948-5956.1000326 (2015).","journal-title":"J. Cancer Sci. Ther."},{"key":"92786_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-9-232","volume":"9","author":"H Shimada","year":"2009","unstructured":"Shimada, H. et al. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. BMC Cancer 9, 1\u20139 (2009).","journal-title":"BMC Cancer"},{"key":"92786_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2017.04.047","volume":"243","author":"PM Chen","year":"2017","unstructured":"Chen, P. M. et al. Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome. Int. J. Cardiol. 243, 1\u20138 (2017).","journal-title":"Int. J. Cardiol."},{"key":"92786_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jjco\/hyu096","volume":"44","author":"S Tsugane","year":"2014","unstructured":"Tsugane, S. & Sawada, N. The JPHC study: Design and some findings on the typical Japanese diet. Jpn. J. Clin. Oncol. 44, 777\u2013782. https:\/\/doi.org\/10.1093\/jjco\/hyu096 (2014).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"92786_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2013.06.013","volume":"230","author":"A Ikeda","year":"2013","unstructured":"Ikeda, A. et al. The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study. Atherosclerosis 230, 67\u201372 (2013).","journal-title":"Atherosclerosis"},{"key":"92786_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transplant"},{"key":"92786_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/01616412.2018.1446283","volume":"40","author":"H Zhu","year":"2018","unstructured":"Zhu, H., Li, Z., Lv, J. & Zhao, R. Effects of cerebral small vessel disease on the outcome of patients with ischemic stroke caused by large artery atherosclerosis. Neurol. Res. 40, 381\u2013390 (2018).","journal-title":"Neurol. Res."},{"key":"92786_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1083\/jcb.137.4.835","volume":"137","author":"F Simpson","year":"1997","unstructured":"Simpson, F., Peden, A. A., Christopoulou, L. & Robinson, M. S. Characterization of the adaptor-related protein complex, AP-3. J. Cell Biol. 137, 835\u2013845. https:\/\/doi.org\/10.1083\/jcb.137.4.835 (1997).","journal-title":"J. Cell Biol."},{"key":"92786_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood-2015-09-671636","volume":"127","author":"S Ammann","year":"2016","unstructured":"Ammann, S. et al. Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome. Blood 127, 997\u20131006. https:\/\/doi.org\/10.1182\/blood-2015-09-671636 (2016).","journal-title":"Blood"},{"key":"92786_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0896-6273(00)80519-x","volume":"21","author":"P Kantheti","year":"1998","unstructured":"Kantheti, P. et al. Mutation in AP-3 \u03b4 in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 21, 111\u2013122. https:\/\/doi.org\/10.1016\/s0896-6273(00)80519-x (1998).","journal-title":"Neuron"},{"key":"92786_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4065\/81.1.59","volume":"81","author":"DA Vorchheimer","year":"2006","unstructured":"Vorchheimer, D. A. & Becker, R. Platelets in atherothrombosis. Mayo Clin. Proc. 81, 59\u201368 (2006).","journal-title":"Mayo Clin. Proc."},{"key":"92786_CR39","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/joim.12296","volume":"276","author":"L Badimon","year":"2014","unstructured":"Badimon, L. & Vilahur, G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J. Intern. Med. 276, 618\u2013632 (2014).","journal-title":"J. Intern. Med."},{"key":"92786_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ejhg.2014.110","volume":"23","author":"M Hirokawa","year":"2015","unstructured":"Hirokawa, M. et al. A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese. Eur. J. Hum. Genet. 23, 374\u2013380. https:\/\/doi.org\/10.1038\/ejhg.2014.110 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"92786_CR41","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0704849104","volume":"104","author":"K Xiao","year":"2007","unstructured":"Xiao, K. et al. Functional specialization of \u03b2-arrestin interactions revealed by proteomic analysis. Proc. Natl. Acad. Sci. USA 104, 12011\u201312016. https:\/\/doi.org\/10.1073\/pnas.0704849104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"92786_CR42","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1016\/j.bmc.2010.10.043","volume":"18","author":"P Naik","year":"2010","unstructured":"Naik, P., Murumkar, P., Giridhar, R. & Yadav, M. R. Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists: A perspective. Bioorg. Med. Chem. 18, 8418\u20138456. https:\/\/doi.org\/10.1016\/j.bmc.2010.10.043 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"92786_CR43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.CIR.103.6.904","volume":"103","author":"M Burnier","year":"2001","unstructured":"Burnier, M. Angiotensin II type 1 receptor blockers. Circulation 103, 904\u2013912. https:\/\/doi.org\/10.1161\/01.CIR.103.6.904 (2001).","journal-title":"Circulation"},{"key":"92786_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(99)10365-9","volume":"355","author":"M Burnier","year":"2000","unstructured":"Burnier, M. & Brunner, H. R. Angiotensin II receptor antagonists. Lancet 355, 637\u2013645. https:\/\/doi.org\/10.1016\/S0140-6736(99)10365-9 (2000).","journal-title":"Lancet"},{"key":"92786_CR45","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1021\/jm7011563","volume":"51","author":"A Cappelli","year":"2008","unstructured":"Cappelli, A. et al. Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems. J. Med. Chem. 51, 2137\u20132146. https:\/\/doi.org\/10.1021\/jm7011563 (2008).","journal-title":"J. Med. Chem."},{"key":"92786_CR46","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/circulationaha.111.070680","volume":"125","author":"J Bellien","year":"2012","unstructured":"Bellien, J. et al. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension. Circulation 125, 1266\u20131275. https:\/\/doi.org\/10.1161\/circulationaha.111.070680 (2012).","journal-title":"Circulation"},{"key":"92786_CR47","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/HYPERTENSIONAHA.115.06597","volume":"67","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. Impaired endothelial repair capacity of early endothelial progenitor cells in hypertensive patients with primary hyperaldosteronemia: Role of 5,6,7,8-tetrahydrobiopterin oxidation and endothelial nitric oxide synthase uncoupling. Hypertension 67, 430\u2013439. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06597 (2016).","journal-title":"Hypertension"},{"key":"92786_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell, M. J. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet 376, 112\u2013123. https:\/\/doi.org\/10.1016\/S0140-6736(10)60834-3 (2010).","journal-title":"Lancet"},{"key":"92786_CR49","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.02953","volume":"63","author":"KM Sanfilippo","year":"2014","unstructured":"Sanfilippo, K. M. et al. Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women. Hypertension 63, 934\u2013941. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02953 (2014).","journal-title":"Hypertension"},{"key":"92786_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000000753","volume":"94","author":"LM Sun","year":"2015","unstructured":"Sun, L. M. et al. Hypertension and subsequent genitourinary and gynecologic cancers risk: A population-based cohort study. Medicine (United States) 94, 1\u20138. https:\/\/doi.org\/10.1097\/MD.0000000000000753 (2015).","journal-title":"Medicine (United States)"},{"key":"92786_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep44877","volume":"7","author":"H Han","year":"2017","unstructured":"Han, H. et al. Hypertension and breast cancer risk: A systematic review and meta-analysis. Sci. Rep. 7, 1\u20139. https:\/\/doi.org\/10.1038\/srep44877 (2017).","journal-title":"Sci. Rep."},{"key":"92786_CR52","doi-asserted-by":"publisher","first-page":"88475","DOI":"10.18632\/oncotarget.19290","volume":"8","author":"N Cambados","year":"2017","unstructured":"Cambados, N. et al. Angiotensin-(1\u20137) counteracts the transforming effects triggered by angiotensin II in breast cancer cells. Oncotarget 8, 88475\u201388487. https:\/\/doi.org\/10.18632\/oncotarget.19290 (2017).","journal-title":"Oncotarget"},{"key":"92786_CR53","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.3892\/ol.2017.6826","volume":"14","author":"P Sobczuk","year":"2017","unstructured":"Sobczuk, P., Szczylik, C., Porta, C. & Czarnecka, A. M. Renin angiotensin system deregulation as renal cancer risk factor (Review). Oncol. Lett. 14, 5059\u20135068. https:\/\/doi.org\/10.3892\/ol.2017.6826 (2017).","journal-title":"Oncol. Lett."},{"key":"92786_CR54","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/bjc.2016.3","volume":"114","author":"CA Penafuerte","year":"2016","unstructured":"Penafuerte, C. A. et al. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br. J. Cancer 114, 680\u2013687. https:\/\/doi.org\/10.1038\/bjc.2016.3 (2016).","journal-title":"Br. J. Cancer"},{"key":"92786_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0035667","volume":"7","author":"S Rodrigues-Ferreira","year":"2012","unstructured":"Rodrigues-Ferreira, S. et al. Angiotensin ii facilitates breast cancer cell migration and metastasis. PLoS ONE 7, 1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0035667 (2012).","journal-title":"PLoS ONE"},{"key":"92786_CR56","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3109\/00365521.2013.777776","volume":"48","author":"A Masamune","year":"2013","unstructured":"Masamune, A. et al. The angiotensin II type i receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice. Scand. J. Gastroenterol. 48, 602\u2013609. https:\/\/doi.org\/10.3109\/00365521.2013.777776 (2013).","journal-title":"Scand. J. Gastroenterol."},{"key":"92786_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/bios8030067","volume":"8","author":"J Qiu","year":"2018","unstructured":"Qiu, J., Keyser, B., Lin, Z. T. & Wu, T. Autoantibodies as potential biomarkers in breast cancer. Biosensors 8, 67. https:\/\/doi.org\/10.3390\/bios8030067 (2018).","journal-title":"Biosensors"},{"key":"92786_CR58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/FJC.0b013e3181b76713","volume":"54","author":"BY Kang","year":"2009","unstructured":"Kang, B. Y., Wang, W., Palade, P., Sharma, S. G. & Mehta, J. L. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine. J. Cardiovasc. Pharmacol. 54, 327\u2013334. https:\/\/doi.org\/10.1097\/FJC.0b013e3181b76713 (2009).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"92786_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0148210","volume":"11","author":"G H\u00f6rl","year":"2016","unstructured":"H\u00f6rl, G. et al. Simvastatin efficiently lowers small LDL-IgG immune complex levels: A therapeutic quality beyond the lipid-lowering effect. PLoS ONE 11, 1\u201323. https:\/\/doi.org\/10.1371\/journal.pone.0148210 (2016).","journal-title":"PLoS ONE"},{"key":"92786_CR60","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1358\/dot.2002.38.7.820117","volume":"38","author":"YW Aude","year":"2002","unstructured":"Aude, Y. W. & Mehta, J. L. Nonplatelet-mediated effects of aspirin. Drugs Today 38, 501\u2013507. https:\/\/doi.org\/10.1358\/dot.2002.38.7.820117 (2002).","journal-title":"Drugs Today"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92786-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:31:34Z","timestamp":1670063494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92786-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92786"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92786-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13450"}}